Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Tumor Microenvironment of Leukemia and Lymphoma
Uta E. Höpken, Armin Rehm
Trends in cancer (2019) Vol. 5, Iss. 6, pp. 351-364
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Myeloid-derived suppressor cells in hematological malignancies: friends or foes
Meng Lv, Ke Wang, Xiao‐Jun Huang
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 98
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 125-125
Open Access | Times Cited: 81
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
Yoshiaki Abe, Mamiko Sakata‐Yanagimoto, Manabu Fujisawa, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 4, pp. 565-578
Open Access | Times Cited: 64
Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CT
Xiao Jin, Maomao Wei, Shuai Wang, et al.
Journal of Nuclear Medicine (2021) Vol. 63, Iss. 2, pp. 212-217
Open Access | Times Cited: 56
Dissecting causal links between gut microbiota, inflammatory cytokines, and DLBCL: a Mendelian randomization study
Peiyao Jiang, Fangfang Yu, Xiao Zhou, et al.
Blood Advances (2024) Vol. 8, Iss. 9, pp. 2268-2278
Open Access | Times Cited: 8
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Nicole A. Seebacher, Mária Krchniaková, Alexandra E. Stacy, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1801-1801
Open Access | Times Cited: 50
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
Mario Bunse, Janina Marie Pfeilschifter, Julia Bluhm, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
Vincent Cabaud Gibouin, Manon Durand, Ronan Quéré, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 20
Cell Encapsulation and 3D Bioprinting for Therapeutic Cell Transplantation
Amirmasoud Samadi, Ali Moammeri, Mehrab Pourmadadi, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 4, pp. 1862-1890
Closed Access | Times Cited: 20
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Jing Liang, Xiaohui Qiao, Luping Qiu, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 19
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
Haoze Li, Lihong Zhou, Jing Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 39
Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of68Ga-FAPI PET/CT and18F-FDG PET/CT
Xuetao Chen, Shuai Wang, Yumei Lai, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1399-1405
Closed Access | Times Cited: 15
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
Xiaojie Liang, Jia Guo, Baiwei Luo, et al.
Journal Of Big Data (2025) Vol. 12, Iss. 1
Open Access
Decoding the Implications of Zinc in the Development and Therapy of Leukemia
Bo Zhu, Chunhao Yang, Siqi Hua, et al.
Advanced Science (2025)
Open Access
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
Xin Liu, Yufan Lin, Qiqi Zhuang, et al.
Blood Reviews (2025), pp. 101273-101273
Closed Access
A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Jingjing Yang, Qingyang Liu, Xiawei Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114268-114268
Closed Access
TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma
Kyung-Eun Noh, Jun‐Ho Lee, So-Yeon Choi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8706-8706
Open Access | Times Cited: 31
Nanomedicine as a magic bullet for combating lymphoma
Srushti Mahajan, Mayur Aalhate, Santosh Kumar Guru, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 211-236
Closed Access | Times Cited: 20
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Vaishali Bhardwaj, Stephen M. Ansell
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
PSGL-1 decorated with sialyl Lewisa/x promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement
Michael O’Dwyer, Lucy Kirkham-McCarthy, Marina Cerreto, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
Lutz Menzel, Uta E. Höpken, Armin Rehm
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 30
CAR‐T TREK through the lymphoma universe, to boldly go where no other therapy has gone before
Guido Ghilardi, Peter Brændstrup, Elise A. Chong, et al.
British Journal of Haematology (2020) Vol. 193, Iss. 3, pp. 449-465
Open Access | Times Cited: 28
γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
Mateus de Souza Barros, Nilberto Dias de Araújo, Fábio Magalhães-Gama, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment
Xiaoli Lou, Ke Zhao, Jingze Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top